Skip to main content
Top

Cancer Causes & Control

Issue 5/2003

Content (12 Articles)

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)

Joseph A. Tangrea, Paul S. Albert, Elaine Lanza, Karen Woodson, Don Corle, Marsha Hasson, Randall Burt, Bette Caan, Electra Paskett, Frank Iber, J. Walter Kikendall, Peter Lance, Moshe Shike, Joel Weissfeld, Arthur Schatzkin

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)

Francesmary Modugno, Roxana Moslehi, Roberta B. Ness, Deborah Brooks Nelson, Steven Belle, Jeffrey A. Kant, James E. Wheeler, Aimee Wonderlick, David Fishman, Beth Karlan, Harvey Risch, Daniel W. Cramer, Marie-Pierre Dube, Steven A. Narod

Prescription medication use during pregnancy and risk of infant leukemia (United States)

Julie A. Ross, Yang Xie, Stella M. Davies, Xiao-ou Shu, Thomas W. Pendergrass, Leslie L. Robison

Number and size of nevi are influenced by different sun exposure components: implications for the etiology of cutaneous melanoma (Belgium, Germany, France, Italy)

Philippe Autier, Gianluca Severi, Remy Pedeux, Maria-Sofia Cattaruzza, Mathieu Boniol, André Grivegnée, Jean-François Doré

A computerized system to facilitate medical record abstraction in cancer research (United States)

Ann M. Geiger, Sarah M. Greene, Roy E. Pardee III, Gene Hart, Lisa J. Herrinton, Ana M. Macedo, Sharon Rolnick, Emily L. Harris, Mary B. Barton, Joann G. Elmore, Suzanne W. Fletcher

Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case–control study

Ettore Bidoli, Cristina Bosetti, Carlo La Vecchia, Fabio Levi, Maria Parpinel, Renato Talamini, Eva Negri, Luigino Dal Maso, Silvia Franceschi

Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa)

Samuel Shapiro, Lynn Rosenberg, Margaret Hoffman, Judith P. Kelly, Diane D. Cooper, Henri Carrara, Lynnette E. Denny, George du Toit, Bruce R. Allan, Ilse A. Stander, Anna-Lise Williamson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine